AbbVie Inc. said its second-quarter earnings rose as strong global sales of the drug maker's rheumatoid-arthritis drug Humira continued to boost results.
from WSJ.com: US Business http://ift.tt/1zbUfjx
via IFTTT
from WSJ.com: US Business http://ift.tt/1zbUfjx
via IFTTT
No comments:
Post a Comment